실시간 바이오 인텔리전스 · ADC · CGT

함께 비교하는 진짜 ADC · Antibody · CGT 데이터

9,268+프로그램
35+FDA 승인
4,079+모집 중
ADC 1068·Antibody 5456·CGT 2744차세대 추천 →·Data Tier →
9268프로그램35FDA 승인
0오늘 방문
572누적 방문
8122갱신 대기S–CData TierS/A/B차세대1068HER2 breast5456Antibody2744CGT→Psoriasis→NSCLC35FDA 승인
피드Data Tier차세대

추천 비교

비교 도구 →
HER2 ADCEnhertu · Kadcyla · RC48CD19 CAR-TYescarta · KymriahPD-1Keytruda · Opdivo다발골수종Darzalex · BlenrepTROP2 ADCTrodelvy · Dato-DXd · SGNectin-4 · TROP2Padcev · Trodelvy건선 IL pathwayStelara · Cosentyx · SkyriziAnti-VEGF (안과)Eylea · LucentisAnti-TNFHumira · EnbrelIL-12/23Stelara · Skyrizi아토피·IL-13Dupixent · Ebglyss혈우병 유전자치료Hemgenix · Roctavian겸상적혈구 CGTCasgevy · Lyfgenia망막·DMD 유전자치료Luxturna · Elevidys

최근 활동

RSS →

빠른 검색 · 이슈 태그

인기최근 업데이트큐레이션임상 많은갱신 필요ORR최신Phase 3FDA승인프로그램 4,162개
다음 갱신 D-12 · 마지막 7월 13일
CGTBiologicstalePersonGen BioTherapeutics (Suzh…Phase 1

T cell injection targeting CD7 chimeric antigen receptor (T cell injection targeting CD7 chimeric antigen receptor)

CD7-positive Relapsed/Refractory Lymphoid Hematologic Malignancies · FRα

#FR#CGT#Phase1#세포유전치료#CAR-T+4
임상시험 6상태 ACTIVE
AntibodystaleThe Affiliated Nanjing Drum Tow…Phase 2

Triplizumab (Triplizumab)

Bladder Cancer · Bladder Cancer

#BladderCancer#Antibody#Phase2#항체#면역항체+2
임상시험 6상태 ACTIVE
ADCBiologicstaleRochePhase 2

Pola-R- GemOx (Polatuzumab Vedotin combined with Rituximab, Gemcitabine, and Oxaliplatin, Polatuzumab Vedotin combined with Rituximab, Gemcitabine, and Oxaliplatin (Pola-R- GemOx))

Diffuse Large B-Cell Lymphoma · Diffuse Large B-Cell Lymphoma

#DiffuseLargeB-CellLymphoma#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+1
효능 ORR 69.7%임상시험 6상태 RECRUITING
ADCBiologicGlaxoSmithKlinerezetecanPhase 3

Mocertatug rezetecan (Mocertatug rezetecan)

Ovarian Neoplasms · Ovarian Neoplasms

#OvarianNeoplasms#ADC#Phase3#항체약물접합체#antibody-drug-conjugate+3
임상시험 6상태 RECRUITING
AntibodystaleMerckPhase 2

pembrolizumab (Keytruda, Coformulated favezelimab/pembrolizumab)

Metastatic Urothelial Carcinoma; Urothelial Neoplasms · Metastatic Urothelial Carcinoma

#MetastaticUrothelialCarcinoma#Antibody#Phase2#항체#면역항체+3
효능 ORR 6.8%임상시험 6상태 RECRUITING
CGTBiologicstaleShanghai AbelZeta Ltd.Phase 1

C-CAR088 (C-CAR088)

Multiple Myeloma · Multiple Myeloma

#MultipleMyeloma#CGT#Phase1#세포유전치료#CAR-T+2
임상시험 6상태 ACTIVE
CGTBiologicstaleShanghai AbelZeta Ltd.Phase 1

C-CAR-011 (C-CAR-011)

Refractory Diffuse Large B-Cell Lymphoma · FRα

#FR#CGT#Phase1#세포유전치료#CAR-T+3
임상시험 6상태 ACTIVE
ADCBiologicAstraZenecasPhase 3

Sonesitatug vedotin (Sonesitatug vedotin)

Gastric Cancer; Gastroesophageal Junction Adenocarcinoma · Gastric Cancer

#GastricCancer#ADC#Phase3#항체약물접합체#antibody-drug-conjugate+3
임상시험 6상태 RECRUITING
CGTAAVBiologicstaleCSL BehringPhase 3

AAV5-hFIXco-Padua (AAV5-hFIXco-Padua)

Hemophilia B · Hemophilia B

#HemophiliaB#CGT#Phase3#세포유전치료#CAR-T+2
임상시험 5상태 ACTIVE
AntibodystaleXencor, Inc.Phase 2

Vudalimab (Vudalimab)

Ovarian Cancer; Clear Cell Carcinoma · Castration-Sensitive Prostate Carcinoma

#Castration-SensitiveProstateCarc#Antibody#Phase2#항체#면역항체+4
임상시험 5상태 DISCONTINUED
ADCBiologicstaleSeagen Inc.Phase 1

SGN-CD33A (SGN-CD33A)

Acute Myelogenous Leukemia; Acute Myeloid Leukemia · CD33

#CD33#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+3
임상시험 5상태 ACTIVE
AntibodystaleNovartisPhase 3

Investigational Arm - secukinumab (Investigational Arm - secukinumab)

Plaque Psoriasis; Non-alcoholic Fatty Liver Disease · Plaque Psoriasis

#PlaquePsoriasis#Antibody#Phase3#항체#면역항체+3
임상시험 5상태 DISCONTINUED
AntibodystaleSeagen Inc.Phase 2

vadastuximab talirine (vadastuximab talirine)

Myelodysplastic Syndrome · Myelodysplastic Syndrome

#MyelodysplasticSyndrome#Antibody#Phase2#항체#면역항체+2
임상시험 5상태 DISCONTINUED
ADCBiologicstaleNational Cancer Institute (NCI)Phase 2

Larotrectinib Sulfate (Larotrectinib Sulfate)

Advanced Lymphoma; Advanced Malignant Solid Neoplasm · FRα

#FR#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+3
효능 ORR 60%임상시험 5상태 RECRUITING
CGTBiologicstaleGuangzhou Virotech Pharmaceutic…Phase 2

Oncolytic virus VRT106 (Oncolytic virus VRT106)

Pancreatic Cancer · Pancreatic Cancer

#PancreaticCancer#CGT#Phase2#세포유전치료#CAR-T+2
임상시험 5상태 RECRUITING
ADCBiologicstaleDualityBio Inc.Phase 3

DB-1303/BNT323 (DB-1303/BNT323)

HER2-positive Breast Cancer · HER2

#HER2#ADC#Phase3#항체약물접합체#antibody-drug-conjugate+2
임상시험 5상태 RECRUITING
ADCBiologicstaleSeagen Inc.Phase 2

cBR96-Doxorubicin Immunoconjugate (SGN-15, SGN-15 (cBR96-Doxorubicin Immunoconjugate))

Ovarian Neoplasms · Ovarian Neoplasms

#OvarianNeoplasms#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+1
임상시험 5상태 DISCONTINUED
ADCBiologicstaleHoffmann-La RochePhase 2

ZN-A-1041 (ZN-A-1041)

Advanced Solid Tumors; HER2-positive Breast Cancer · HER2

#HER2#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+3
임상시험 5상태 RECRUITING
AntibodystaleJuno Therapeutics, Inc., a Bris…Phase 3

Alnuctamab (Alnuctamab)

Multiple Myeloma · Multiple Myeloma

#MultipleMyeloma#Antibody#Phase3#항체#면역항체+2
임상시험 5상태 DISCONTINUED
ADCBiologicstaleGlaxoSmithKlinePhase 2

GSK3174998 (GSK3174998)

Neoplasms · FRα

#FR#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2
효능 ORR 11.1%임상시험 5상태 RECRUITING
ADCBiologicstaleSanofiPhase 2

Pegenzileukin (Pegenzileukin)

Plasma Cell Myeloma Refractory · FRα

#FR#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2
효능 ORR 92.9%임상시험 5상태 RECRUITING
CGTBiologicstaleShenzhen Geno-Immune Medical In…Phase 2

4SCAR-GD2 (4SCAR-GD2)

Solid Tumor · GD2

#GD2#CGT#Phase2#세포유전치료#CAR-T+3
임상시험 5상태 RECRUITING
CGTBiologicstaleAlberta Precision LaboratoriesPhase 1

GCAR1 (GCAR1)

Alveolar Soft Part Sarcoma (ASPS); Sarcoma · Alveolar Soft Part Sarcoma

#AlveolarSoftPartSarcoma#CGT#Phase1#세포유전치료#CAR-T+4
임상시험 5상태 RECRUITING
AntibodystaleRochePhase 3

rituximab [MabThera] (rituximab [MabThera])

Immune Thrombocytopenia (ITP) · Lymphocytic Leukemia, Chronic

#LymphocyticLeukemiaChronic#Antibody#Phase3#항체#면역항체+3
임상시험 5상태 ACTIVE
CGTBiologicstaleTakedaPhase 2

CD19-CAR-T2 Cells (CD19-CAR-T2 Cells)

B Cell Leukemia; B Cell Lymphoma · CD19

#CD19#CGT#Phase2#세포유전치료#CAR-T+4
임상시험 5상태 ACTIVE

42 / 167 페이지

← 이전다음 →
전체 9,268개 프로그램 보기